Comment
. 2010 May;11(5):412-3; author reply 413.
doi: 10.1016/S1470-2045(10)70065-6.
EGFR mutations in non-small-cell lung cancer
- PMID: 20434712
- DOI: 10.1016/S1470-2045(10)70065-6
Item in Clipboard
Comment
EGFR mutations in non-small-cell lung cancer
Lancet Oncol.
2010 May.
No abstract available
Comment on
-
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial.Lancet Oncol. 2010 Feb;11(2):121-8. doi: 10.1016/S1470-2045(09)70364-X. Epub 2009 Dec 18. Lancet Oncol. 2010. PMID: 20022809 Clinical Trial.
Similar articles
-
Clinical Response to Everolimus of EGFR-Mutation-Positive NSCLC With Primary Resistance to EGFR TKIs.Clin Lung Cancer. 2017 Jan;18(1):e85-e87. doi: 10.1016/j.cllc.2016.08.004. Epub 2016 Oct 4. Clin Lung Cancer. 2017. PMID: 28341110 No abstract available.
-
Tyrosine kinase inhibitors and epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer: to test or not to test?Medicine (Baltimore). 2011 May;90(3):168-170. doi: 10.1097/MD.0b013e31821a2f07. Medicine (Baltimore). 2011. PMID: 21512415 Free PMC article. No abstract available.
-
Rapid screening for EGFR mutations: pros and cons.Cancer J. 2006 Jan-Feb;12(1):17-8. doi: 10.1097/00130404-200601000-00003. Cancer J. 2006. PMID: 16613656 No abstract available.
-
Relevance of epidermal growth factor receptor genomic gain in predicting clinical response to kinase inhibitors in non-small-cell lung cancer.Clin Lung Cancer. 2005 Nov;7(3):163-5. doi: 10.1016/S1525-7304(11)70404-1. Clin Lung Cancer. 2005. PMID: 16354309 Review. No abstract available.
-
Identifying activating mutations in the EGFR gene: prognostic and therapeutic implications in non-small cell lung cancer.J Bras Pneumol. 2015 Jul-Aug;41(4):365-75. doi: 10.1590/S1806-37132015000004531. J Bras Pneumol. 2015. PMID: 26398757 Free PMC article. Review.
Cited by
-
A fluorogenic probe for predicting treatment response in non-small cell lung cancer with EGFR-activating mutations.Nat Commun. 2022 Nov 14;13(1):6944. doi: 10.1038/s41467-022-34627-5. Nat Commun. 2022. PMID: 36376325 Free PMC article.
-
The ubiquitin system: orchestrating cellular signals in non-small-cell lung cancer.Cell Mol Biol Lett. 2020 Jan 16;25:1. doi: 10.1186/s11658-019-0193-6. eCollection 2020. Cell Mol Biol Lett. 2020. PMID: 31988639 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
